Concord Medical Services Holdings Limited (CCM) Income Statement
CCM 2025 at a glance
Fiscal year ended December 31, 2025 · Chinese yuanCCM revenue and net income
Where CCM's revenue goes
2025Each bar shows an amount and its share of revenue. CCM kept −20.2% of revenue as net income.
CCM profit margins
CCM growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +19.9% | −0.8% | +15.6% | −2.9% |
| Gross profit | — | — | +14.6% | −20.7% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CCM income statement in Chinese yuan
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥460.5M | CN¥384.0M | CN¥537.4M | CN¥472.1M | CN¥485.6M | CN¥223.0M | CN¥198.4M | CN¥190.9M | CN¥331.0M | CN¥455.0M |
| Cost of revenue | CN¥434.7M | CN¥463.1M | CN¥614.0M | CN¥624.5M | CN¥542.5M | CN¥209.9M | CN¥214.2M | CN¥171.1M | CN¥233.0M | CN¥286.5M |
| Gross profit | CN¥25.8M | −CN¥79.2M | −CN¥76.6M | −CN¥152.4M | −CN¥56.9M | CN¥13.1M | −CN¥15.8M | CN¥19.8M | CN¥98.0M | CN¥168.5M |
| Research & development | — | — | — | — | — | — | — | CN¥0 | CN¥0 | CN¥0 |
| Sales, general & admin | CN¥265.2M | CN¥453.0M | CN¥386.4M | CN¥372.6M | CN¥401.4M | CN¥320.6M | CN¥345.4M | CN¥313.6M | CN¥281.3M | CN¥276.0M |
| Total operating expenses | CN¥265.2M | CN¥453.0M | CN¥386.4M | CN¥372.6M | CN¥401.4M | CN¥320.6M | CN¥421.5M | CN¥319.0M | CN¥309.9M | CN¥337.1M |
| Operating income | −CN¥239.3M | −CN¥532.2M | −CN¥463.0M | −CN¥525.0M | −CN¥458.3M | −CN¥307.5M | −CN¥437.3M | −CN¥299.2M | −CN¥211.9M | −CN¥168.6M |
| Interest income | CN¥9.7M | CN¥14.0M | CN¥10.8M | CN¥10.0M | CN¥5.9M | CN¥8.4M | CN¥10.4M | CN¥31.7M | CN¥72.4M | CN¥46.5M |
| Interest expense | CN¥152.3M | CN¥193.2M | CN¥165.7M | CN¥120.4M | CN¥73.8M | CN¥81.4M | CN¥28.7M | CN¥46.2M | CN¥90.0M | CN¥89.3M |
| Income before taxes | −CN¥373.4M | −CN¥669.6M | −CN¥555.6M | −CN¥839.9M | −CN¥529.2M | −CN¥441.7M | −CN¥391.1M | −CN¥225.2M | −CN¥253.9M | −CN¥204.6M |
| Income taxes | CN¥6.1M | −CN¥17.5M | −CN¥24.6M | −CN¥70.9M | −CN¥6.6M | −CN¥37.6M | −CN¥39.0M | CN¥34.1M | CN¥31.8M | CN¥60.5M |
| Net income | −CN¥92.8M | −CN¥308.2M | −CN¥297.7M | −CN¥489.7M | −CN¥271.4M | −CN¥404.0M | −CN¥307.0M | −CN¥234.9M | −CN¥284.3M | −CN¥261.9M |
| EBITDA | −CN¥71.8M | −CN¥345.6M | −CN¥334.5M | −CN¥392.2M | −CN¥354.2M | −CN¥206.4M | −CN¥295.4M | −CN¥239.2M | −CN¥88.5M | CN¥21.5M |
| Gross margin | 5.6% | −20.6% | −14.3% | −32.3% | −11.7% | 5.9% | −8.0% | 10.4% | 29.6% | 37.0% |
| Operating margin | −52.0% | −138.6% | −86.2% | −111.2% | −94.4% | −137.9% | −220.5% | −156.8% | −64.0% | −37.1% |
| Net margin | −20.2% | −80.3% | −55.4% | −103.7% | −55.9% | −181.2% | −154.8% | −123.0% | −85.9% | −57.5% |
| Mar '26 | Sep '25 | Mar '25 | Sep '24 | Mar '24 | Sep '23 | Jun '23 | Mar '23 | Sep '22 | Jun '22 | Mar '22 | Dec '21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥255.1M | CN¥129.9M | CN¥100.3M | CN¥82.6M | CN¥109.4M | CN¥126.4M | CN¥142.3M | CN¥142.3M | CN¥163.9M | CN¥72.1M | CN¥72.1M | CN¥292.7M |
| Cost of revenue | CN¥225.6M | CN¥114.9M | CN¥102.4M | CN¥101.4M | CN¥130.2M | CN¥146.0M | CN¥161.0M | CN¥161.0M | CN¥195.7M | CN¥116.5M | CN¥116.5M | CN¥352.0M |
| Gross profit | CN¥29.5M | CN¥15.1M | −CN¥2.1M | −CN¥18.8M | −CN¥20.8M | −CN¥19.6M | −CN¥18.7M | −CN¥18.7M | −CN¥31.8M | −CN¥44.4M | −CN¥44.4M | −CN¥59.3M |
| Sales, general & admin | — | CN¥62.4M | CN¥70.2M | CN¥148.4M | CN¥78.1M | CN¥104.9M | CN¥75.1M | CN¥75.1M | CN¥107.9M | CN¥78.4M | CN¥78.4M | CN¥215.1M |
| Total operating expenses | CN¥122.5M | CN¥73.5M | CN¥70.2M | CN¥148.4M | CN¥78.1M | CN¥318.9M | −CN¥125.7M | −CN¥125.7M | CN¥353.5M | CN¥78.4M | CN¥78.4M | — |
| Operating income | −CN¥92.9M | −CN¥1.7M | −CN¥72.3M | −CN¥167.2M | −CN¥98.9M | −CN¥338.5M | CN¥107.0M | CN¥107.0M | −CN¥385.3M | −CN¥122.8M | −CN¥122.8M | −CN¥274.4M |
| Interest income | — | — | — | — | — | — | — | — | — | CN¥25.4M | — | CN¥73.9M |
| Interest expense | CN¥63.5M | CN¥5.8M | CN¥41.5M | CN¥58.3M | CN¥31.3M | CN¥38.1M | CN¥39.3M | CN¥39.3M | CN¥22.8M | CN¥32.4M | CN¥32.4M | — |
| Income before taxes | −CN¥184.3M | −CN¥3.5M | −CN¥92.8M | −CN¥166.1M | −CN¥168.7M | −CN¥160.9M | −CN¥116.9M | −CN¥116.9M | −CN¥284.0M | −CN¥135.9M | −CN¥135.9M | −CN¥352.2M |
| Income taxes | −CN¥13.5M | −CN¥253,428 | CN¥9.9M | CN¥4.4M | −CN¥4.3M | −CN¥578,000 | −CN¥11.7M | −CN¥11.7M | −CN¥30.6M | −CN¥4.8M | −CN¥4.8M | −CN¥617,000 |
| Net income | −CN¥64.5M | −CN¥32.8M | −CN¥13.6M | −CN¥68.0M | −CN¥86.1M | −CN¥103.3M | −CN¥45.5M | −CN¥45.5M | −CN¥187.5M | −CN¥57.3M | −CN¥57.3M | −CN¥181.1M |
| EBITDA | −CN¥18.9M | −CN¥17.1M | −CN¥42.0M | −CN¥137.5M | −CN¥69.2M | −CN¥93.7M | −CN¥50.8M | −CN¥76.2M | −CN¥116.1M | −CN¥99.2M | −CN¥99.2M | — |
| Gross margin | 11.6% | 11.6% | −2.1% | −22.7% | −19.0% | −15.5% | −13.2% | −13.2% | −19.4% | −61.5% | −61.5% | −20.2% |
| Operating margin | −36.4% | −1.3% | −72.1% | −202.5% | −90.4% | −267.7% | 75.2% | 75.2% | −235.1% | −170.3% | −170.3% | −93.7% |
| Net margin | −25.3% | −25.3% | −13.5% | −82.3% | −78.7% | −81.7% | −32.0% | −32.0% | −114.4% | −79.5% | −79.5% | −61.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in Chinese yuan as reported in CCM's financial statements (latest annual report filed April 29, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CCM financial results
In fiscal year 2025 (ended December 31, 2025), Concord Medical Services reported revenue of CN¥460.5 million, up 19.9% from the year before. It had a net loss of CN¥92.8 million, a net profit margin of −20.2%. Over five years revenue grew at an average rate of 15.6% a year. Figures are in Chinese yuan, the currency of its financial statements.
See the CCM stock overview for the latest quote and news, or the CCM chart for price history and technical indicators.
CCM income statement FAQ
What is Concord Medical Services's annual revenue?
Concord Medical Services reported total revenue of CN¥460.5 million for fiscal year 2025, which ended on December 31, 2025. That was up 19.9% from CN¥384.0 million the previous year.
Is Concord Medical Services profitable?
No. Concord Medical Services reported a net loss of CN¥92.8 million in fiscal 2025, a net profit margin of −20.2%; its operating margin was −52.0%.
What is Concord Medical Services's gross margin?
Concord Medical Services's gross margin was 5.6% in fiscal 2025: for every $100 of revenue, Concord Medical Services kept $6 after the direct cost of its products and services.
How fast is Concord Medical Services growing?
Revenue grew 15.6% a year on average over the last five fiscal years, from CN¥223.0 million to CN¥460.5 million.
When does Concord Medical Services's fiscal year end?
Concord Medical Services's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 29, 2026.